Both genes were reported to have potential regulatory impact on RAS, where RASSF2 seems to modulate some of the growth inhibitory response mediated by RAS and may serve as tumor suppressor [23,24], and RASA3 may act as a suppressor of RAS function and thereby controls the cellular proliferation and differentiation [25]. The gene discussed is RASSF2; the disease is neoplasm.